DCLK3 and leukemia: An important point that must be developed and clarified is the involvement of AM in the post-chemotherapy persistence of solid tumor cells; in leukemia, whether targeting CLR prevents relapse or not, and the methylation patterns of certain genes in this disease must be investigated [183,186].